CARL
Price
$12.59
Change
-$0.07 (-0.55%)
Updated
Jul 31 closing price
Capitalization
342.26M
2 days until earnings call
Intraday BUY SELL Signals
MGRX
Price
$0.56
Change
+$0.27 (+93.10%)
Updated
Jul 31 closing price
Capitalization
9.56M
Intraday BUY SELL Signals
Interact to see
Advertisement

CARL vs MGRX

CARL vs MGRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CARL vs. MGRX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARL is a StrongBuy and MGRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (CARL: $12.59 vs. MGRX: $0.56)
Brand notoriety: CARL and MGRX are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: CARL: 33% vs. MGRX: 3832%
Market capitalization -- CARL: $342.26M vs. MGRX: $9.56M
CARL [@Services to the Health Industry] is valued at $342.26M. MGRX’s [@Services to the Health Industry] market capitalization is $9.56M. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $33.1B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARL’s FA Score shows that 0 FA rating(s) are green whileMGRX’s FA Score has 1 green FA rating(s).

  • CARL’s FA Score: 0 green, 5 red.
  • MGRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CARL and MGRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARL’s TA Score shows that 5 TA indicator(s) are bullish while MGRX’s TA Score has 6 bullish TA indicator(s).

  • CARL’s TA Score: 5 bullish, 4 bearish.
  • MGRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MGRX is a better buy in the short-term than CARL.

Price Growth

CARL (@Services to the Health Industry) experienced а +16.57% price change this week, while MGRX (@Services to the Health Industry) price change was +6.99% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.57%. For the same industry, the average monthly price growth was -6.35%, and the average quarterly price growth was +0.20%.

Reported Earning Dates

CARL is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Services to the Health Industry (-1.57% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CARL($342M) has a higher market cap than MGRX($9.56M). CARL YTD gains are higher at: 1.943 vs. MGRX (-24.716). MGRX has higher annual earnings (EBITDA): -17.5M vs. CARL (-30.88M). CARL has more cash in the bank: 97M vs. MGRX (175K). MGRX has less debt than CARL: MGRX (294K) vs CARL (17.3M). CARL has higher revenues than MGRX: CARL (56.4M) vs MGRX (415K).
CARLMGRXCARL / MGRX
Capitalization342M9.56M3,576%
EBITDA-30.88M-17.5M176%
Gain YTD1.943-24.716-8%
P/E RatioN/AN/A-
Revenue56.4M415K13,590%
Total Cash97M175K55,429%
Total Debt17.3M294K5,884%
TECHNICAL ANALYSIS
Technical Analysis
CARLMGRX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 7 days ago
90%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CARL
Daily Signal:
Gain/Loss:
MGRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGRCX22.580.43
+1.94%
Loomis Sayles Growth C
GSSUX45.720.10
+0.22%
Goldman Sachs Small Cap Value R6
TEMQX17.010.03
+0.18%
Franklin Mutual Quest C
HFCVX25.970.01
+0.04%
Hennessy Cornerstone Value Investor
VFPIX20.49-0.04
-0.19%
Private Capital Management Value I

CARL and

Correlation & Price change

A.I.dvisor tells us that CARL and TEM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CARL and TEM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARL
1D Price
Change %
CARL100%
-0.55%
TEM - CARL
28%
Poorly correlated
-0.95%
PRVA - CARL
26%
Poorly correlated
-0.80%
SDGR - CARL
24%
Poorly correlated
-1.37%
TALK - CARL
24%
Poorly correlated
+0.19%
MGRX - CARL
21%
Poorly correlated
+89.75%
More

MGRX and

Correlation & Price change

A.I.dvisor tells us that MGRX and TALK have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MGRX and TALK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGRX
1D Price
Change %
MGRX100%
+89.75%
TALK - MGRX
22%
Poorly correlated
+0.19%
SAP - MGRX
22%
Poorly correlated
+1.51%
LIDR - MGRX
22%
Poorly correlated
+3.64%
TDOC - MGRX
21%
Poorly correlated
+1.98%
UBER - MGRX
21%
Poorly correlated
-0.01%
More